Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 1/2019

01-01-2019 | Original Article

Microorganisms associated with respiratory syncytial virus pneumonia in the adult population

Authors: M. Jeannoël, G. Lina, J. P. Rasigade, B. Lina, F. Morfin, Jean Sebastien Casalegno

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Respiratory syncytial virus (RSV) has been recognized as responsible for severe respiratory illness in adults, especially in the elderly. While pneumonia is commonly observed during RSV infection, the burden and epidemiology of bacterial superinfection is poorly understood. The aim of this study was to identify microorganisms associated with RSV-positive pneumonia in adults. A retrospective study was conducted during three consecutive winters (October to April 2013–2016) in the University Hospital of Lyon, France. During RSV circulation periods, a systematic RSV screening was performed by reverse-transcription PCR on all respiratory samples collected from adults. Records of RSV-positive patients were subsequently analyzed to identify radiologically confirmed pneumonia cases. Bacteria were identified by standard bacteriology cultures or urinary antigen screening and classified as potentially causative of pneumonia if quantification was above the specific threshold as defined by the European Manual of Clinical Microbiology. Overall, 14,792 adult respiratory samples were screened for RSV detection by PCR. In total, 292 had a positive RSV detection (2.0%) among which 89 presented with pneumonia including 27 bacterial superinfections (9.3%) with Streptococcus pneumonia, Haemophilus influenza, Staphylococcus aureus, Pseudomonas aeruginosa, and Moraxella catarrhalis. Most patients were elderly (55.6%) and patients with comorbidities (77.8%). A more severe outcome was observed for RSV-bacteria-associated pneumonia compared with RSV pneumonia: length of stay was significantly longer (16 days vs 10 days) and ICU hospitalization more frequent (66.7% vs 21.0%) (p < 0.05). In conclusion, we did not observe major differences in the epidemiology of bacterial superinfections in RSV-positive pneumonia compared to reports on post-influenza pneumonia.
Literature
1.
go back to reference Kwon YS, Park SH, Kim MA, Kim HJ, Park JS, Lee MY, Lee CW, Dauti S, Choi WI (2017) Risk of mortality associated with respiratory syncytial virus and influenza infection in adults. BMC Infect Dis 17:785CrossRefPubMedPubMedCentral Kwon YS, Park SH, Kim MA, Kim HJ, Park JS, Lee MY, Lee CW, Dauti S, Choi WI (2017) Risk of mortality associated with respiratory syncytial virus and influenza infection in adults. BMC Infect Dis 17:785CrossRefPubMedPubMedCentral
2.
go back to reference Voiriot G, Visseaux B, Cohen J, Nguyen LB, Neuville M, Morbieu C, Burdet C, Radjou A, Lescure FX, Smonig R, Armand-Lefevre L, Mourvillier B, Yazdanpanah Y, Soubirou JF, Ruckly S, Houhou-Fidouh N, Timsit JF (2016) Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia. Crit Care 20:375CrossRefPubMedPubMedCentral Voiriot G, Visseaux B, Cohen J, Nguyen LB, Neuville M, Morbieu C, Burdet C, Radjou A, Lescure FX, Smonig R, Armand-Lefevre L, Mourvillier B, Yazdanpanah Y, Soubirou JF, Ruckly S, Houhou-Fidouh N, Timsit JF (2016) Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia. Crit Care 20:375CrossRefPubMedPubMedCentral
3.
go back to reference Falsey AR (2005) Respiratory syncytial virus infection in elderly and high-risk adults. Exp Lung Res 31(Suppl 1):77PubMed Falsey AR (2005) Respiratory syncytial virus infection in elderly and high-risk adults. Exp Lung Res 31(Suppl 1):77PubMed
4.
go back to reference Jennings LC, Anderson TP, Beynon KA, Chua A, Laing RT, Werno AM, Young SA, Chambers ST, Murdoch DR (2008) Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 63:42–48CrossRefPubMed Jennings LC, Anderson TP, Beynon KA, Chua A, Laing RT, Werno AM, Young SA, Chambers ST, Murdoch DR (2008) Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 63:42–48CrossRefPubMed
6.
go back to reference Gaymard A, Bouscambert-Duchamp M, Pichon M, Frobert E, Vallee J, Lina B, Casalegno JS, Morfin F (2018) Genetic characterization of respiratory syncytial virus highlights a new BA genotype and emergence of the ON1 genotype in Lyon, France, between 2010 and 2014. J Clin Virol 102:12–18CrossRefPubMed Gaymard A, Bouscambert-Duchamp M, Pichon M, Frobert E, Vallee J, Lina B, Casalegno JS, Morfin F (2018) Genetic characterization of respiratory syncytial virus highlights a new BA genotype and emergence of the ON1 genotype in Lyon, France, between 2010 and 2014. J Clin Virol 102:12–18CrossRefPubMed
7.
go back to reference Cornaglia G, Courcol R, Hermann J (2012) European manual of clinical microbiology. Basel: European Society for Clinical Microbiology and Infections Diseases : Société française de microbiologie Cornaglia G, Courcol R, Hermann J (2012) European manual of clinical microbiology. Basel: European Society for Clinical Microbiology and Infections Diseases : Société française de microbiologie
8.
go back to reference Datta S, Walsh EE, Peterson DR, Falsey AR (2017) Can analysis of routine viral testing provide accurate estimates of respiratory syncytial virus disease burden in adults? J Infect Dis 215:1706–1710CrossRefPubMed Datta S, Walsh EE, Peterson DR, Falsey AR (2017) Can analysis of routine viral testing provide accurate estimates of respiratory syncytial virus disease burden in adults? J Infect Dis 215:1706–1710CrossRefPubMed
9.
go back to reference Visseaux B, Burdet C, Voiriot G, Lescure FX, Chougar T, Brugiere O, Crestani B, Casalino E, Charpentier C, Descamps D, Timsit JF, Yazdanpanah Y, Houhou-Fidouh N (2017) Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016. PLoS One 12:e0180888CrossRefPubMedPubMedCentral Visseaux B, Burdet C, Voiriot G, Lescure FX, Chougar T, Brugiere O, Crestani B, Casalino E, Charpentier C, Descamps D, Timsit JF, Yazdanpanah Y, Houhou-Fidouh N (2017) Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016. PLoS One 12:e0180888CrossRefPubMedPubMedCentral
10.
go back to reference Mayer LM, Kahlert C, Rassouli F, Vernazza P, Albrich WC (2017) Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study. Pneumonia (Nathan) 9:4CrossRef Mayer LM, Kahlert C, Rassouli F, Vernazza P, Albrich WC (2017) Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study. Pneumonia (Nathan) 9:4CrossRef
11.
go back to reference Malosh RE, Martin ET, Callear AP, Petrie JG, Lauring AS, Lamerato L, Fry AM, Ferdinands J, Flannery B, Monto AS (2017) Respiratory syncytial virus hospitalization in middle-aged and older adults. J Clin Virol 96:37–43CrossRefPubMedPubMedCentral Malosh RE, Martin ET, Callear AP, Petrie JG, Lauring AS, Lamerato L, Fry AM, Ferdinands J, Flannery B, Monto AS (2017) Respiratory syncytial virus hospitalization in middle-aged and older adults. J Clin Virol 96:37–43CrossRefPubMedPubMedCentral
12.
go back to reference Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK (2012) Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis 206:56–62CrossRefPubMedPubMedCentral Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK (2012) Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis 206:56–62CrossRefPubMedPubMedCentral
13.
go back to reference Walsh EE (2011) Respiratory syncytial virus infection in adults. Semin Respir Crit Care Med 32:423–432CrossRefPubMed Walsh EE (2011) Respiratory syncytial virus infection in adults. Semin Respir Crit Care Med 32:423–432CrossRefPubMed
14.
go back to reference Loubet P, Lenzi N, Valette M, Foulongne V, Krivine A, Houhou N, Lagathu G, Rogez S, Alain S, Duval X, Galtier F, Postil D, Tattevin P, Vanhems P, Carrat F, Lina B, Launay O, FLUVAC Study Group (2017) Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France. Clin Microbiol Infect 23:253–259CrossRefPubMed Loubet P, Lenzi N, Valette M, Foulongne V, Krivine A, Houhou N, Lagathu G, Rogez S, Alain S, Duval X, Galtier F, Postil D, Tattevin P, Vanhems P, Carrat F, Lina B, Launay O, FLUVAC Study Group (2017) Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France. Clin Microbiol Infect 23:253–259CrossRefPubMed
15.
go back to reference Jung HS, Kang BJ, Ra SW, Seo KW, Jegal Y, Jun JB et al (2017) Elucidation of bacterial pneumonia-causing pathogens in patients with respiratory viral infection. Tuberc Respir Dis (Seoul) 80(4):358–367 Jung HS, Kang BJ, Ra SW, Seo KW, Jegal Y, Jun JB et al (2017) Elucidation of bacterial pneumonia-causing pathogens in patients with respiratory viral infection. Tuberc Respir Dis (Seoul) 80(4):358–367
16.
go back to reference Leone M, Bouadma L, Bouhemad B, Brissaud O, Dauger S, Gibot S, Hraiech S, Jung B, Kipnis E, Launey Y, Luyt CE, Margetis D, Michel F, Mokart D, Montravers P, Monsel A, Nseir S, Pugin J, Roquilly A, Velly L, Zahar JR, Bruyere R, Chanques G (2017) Hospital-acquired pneumonia in ICU. Anaesth Crit Care Pain Med 37:83–98CrossRefPubMed Leone M, Bouadma L, Bouhemad B, Brissaud O, Dauger S, Gibot S, Hraiech S, Jung B, Kipnis E, Launey Y, Luyt CE, Margetis D, Michel F, Mokart D, Montravers P, Monsel A, Nseir S, Pugin J, Roquilly A, Velly L, Zahar JR, Bruyere R, Chanques G (2017) Hospital-acquired pneumonia in ICU. Anaesth Crit Care Pain Med 37:83–98CrossRefPubMed
17.
go back to reference McCullers JA (2014) The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol 12:252–262CrossRefPubMed McCullers JA (2014) The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol 12:252–262CrossRefPubMed
Metadata
Title
Microorganisms associated with respiratory syncytial virus pneumonia in the adult population
Authors
M. Jeannoël
G. Lina
J. P. Rasigade
B. Lina
F. Morfin
Jean Sebastien Casalegno
Publication date
01-01-2019
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 1/2019
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3407-3

Other articles of this Issue 1/2019

European Journal of Clinical Microbiology & Infectious Diseases 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.